Gilead Sciences, Inc. (GILD) Misses Q1 EPS by 3c
Get Alerts GILD Hot Sheet
Price: $65.27 -2.7%
Revenue Growth %: +3.9%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +3.9%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q1 EPS of $0.91, $0.03 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.2 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- Terex (TEX) Tops Q1 EPS by 24c, provides guidance
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!